These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32423258)

  • 21. The Induction of Combined Hyperthermal Ablation Effect of Irreversible Electroporation with Polydopamine Nanoparticle-Coated Electrodes.
    Jeon SM; Davaa E; Jenjob R; Pechyen C; Natphopsuk S; Jeong S; Yoo HJ; Yang SG
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of metallic implants on electroporation therapies: feasibility of irreversible electroporation for brachytherapy salvage.
    Neal RE; Smith RL; Kavnoudias H; Rosenfeldt F; Ou R; Mclean CA; Davalos RV; Thomson KR
    Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1638-1645. PubMed ID: 23942593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological Response to 5 kHz Irreversible Electroporation in a Porcine Liver Model.
    Kim HB; Baik KY; Sung CK
    Technol Cancer Res Treat; 2023; 22():15330338231171767. PubMed ID: 37125478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is irreversible electroporation safe and effective in the treatment of hepatobiliary and pancreatic cancers?
    Wu LM; Zhang LL; Chen XH; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):117-124. PubMed ID: 30655073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulse Parameters and Thresholds for (ir)Reversible Electroporation on Hepatocellular Carcinoma Cells
    Lindelauf KHK; Baragona M; Baumann M; Maessen RTH; Ritter A
    Technol Cancer Res Treat; 2023; 22():15330338221136694. PubMed ID: 36600679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
    Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
    Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation.
    Neal RE; Millar JL; Kavnoudias H; Royce P; Rosenfeldt F; Pham A; Smith R; Davalos RV; Thomson KR
    Prostate; 2014 May; 74(5):458-68. PubMed ID: 24442790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer.
    Moris D; Machairas N; Tsilimigras DI; Prodromidou A; Ejaz A; Weiss M; Hasemaki N; Felekouras E; Pawlik TM
    Ann Surg Oncol; 2019 Jun; 26(6):1657-1668. PubMed ID: 30843163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thermal Energy during Irreversible Electroporation and the Influence of Different Ablation Parameters.
    van den Bos W; Scheffer HJ; Vogel JA; Wagstaff PG; de Bruin DM; de Jong MC; van Gemert MJ; de la Rosette JJ; Meijerink MR; Klaessens JH; Verdaasdonk RM
    J Vasc Interv Radiol; 2016 Mar; 27(3):433-43. PubMed ID: 26703782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney.
    Olweny EO; Kapur P; Tan YK; Park SK; Adibi M; Cadeddu JA
    Urology; 2013 Mar; 81(3):679-84. PubMed ID: 23290141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irreversible electroporation for the ablation of liver tumors: are we there yet?
    Charpentier KP
    Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endovascular nonthermal irreversible electroporation: a finite element analysis.
    Maor E; Rubinsky B
    J Biomech Eng; 2010 Mar; 132(3):031008. PubMed ID: 20459196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of magnetic anchoring electrode-assisted irreversible electroporation for gastric tissue ablation.
    Ren F; Li Q; Hu L; Yan X; Gao Z; Zhang J; Gao W; Zhang Z; Chang P; Chen X; Chu D; Wu R; Lv Y
    Surg Endosc; 2020 Feb; 34(2):580-589. PubMed ID: 31011863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irreversible Electroporation Enhanced by Radiofrequency Ablation: An In Vitro and Computational Study in a 3D Liver Tumor Model.
    Fang Z; Mao H; Moser MAJ; Zhang W; Qian Z; Zhang B
    Ann Biomed Eng; 2021 Sep; 49(9):2126-2138. PubMed ID: 33594637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Influence of a Metal Stent on the Distribution of Thermal Energy during Irreversible Electroporation.
    Scheffer HJ; Vogel JA; van den Bos W; Neal RE; van Lienden KP; Besselink MG; van Gemert MJ; van der Geld CW; Meijerink MR; Klaessens JH; Verdaasdonk RM
    PLoS One; 2016; 11(2):e0148457. PubMed ID: 26844550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irreversible electroporation ablation: creation of large-volume ablation zones in in vivo porcine liver with four-electrode arrays.
    Appelbaum L; Ben-David E; Faroja M; Nissenbaum Y; Sosna J; Goldberg SN
    Radiology; 2014 Feb; 270(2):416-24. PubMed ID: 24126371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial.
    Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB
    Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Feasibility of Enhancing Susceptibility of Glioblastoma Cells to IRE Using a Calcium Adjuvant.
    Wasson EM; Ivey JW; Verbridge SS; Davalos RV
    Ann Biomed Eng; 2017 Nov; 45(11):2535-2547. PubMed ID: 28849278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Influence of Irreversible Electroporation Parameters on the Size of the Ablation Zone and Thermal Effects: A Systematic Review.
    Hogenes AM; Overduin CG; Slump CH; van Laarhoven CJHM; Fütterer JJ; Ten Broek RPG; Stommel MWJ
    Technol Cancer Res Treat; 2023; 22():15330338221125003. PubMed ID: 36598035
    [No Abstract]   [Full Text] [Related]  

  • 40. Predicting irreversible electroporation-induced tissue damage by means of magnetic resonance electrical impedance tomography.
    Kranjc M; Kranjc S; Bajd F; Serša G; Serša I; Miklavčič D
    Sci Rep; 2017 Sep; 7(1):10323. PubMed ID: 28871138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.